CLINICAL_TRIALS
withdrawal
· 2018-05-04
Clinical Trial Update: Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia [Phase 1]
Summary
A phase 1 trial evaluating volasertib in combination with induction chemotherapy for acute myeloid leukemia has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: AML | Phase 1 | Status: WITHDRAWN